Skip to main content
. 2012 Dec 17;12:257. doi: 10.1186/1472-6882-12-257

Figure 4.

Figure 4

Effects of SCTE on the levels of total and OVA-specific IgE in plasma. Plasma was collected from mice 48 h after the final OVA challenge. Each sample was analyzed using ELISA. (A) Total IgE level, (B) OVA-specific IgE level. PBS/PBS, PBS-sensitized/challenged, negative control (PBS only); OVA/PBS, OVA-sensitized/challenged mice, (PBS only); OVA/mon, OVA-sensitized/challenged mice (montelukast 30 mg/kg); OVA/SCTE-200, OVA-sensitized/challenged mice (SCTE 200 mg/kg); OVA/SCTE-400, OVA-sensitized/challenged mice (SCTE 400 mg/kg). SCTE or montelukast was given 1 h before the challenge. Significantly different from PBS/PBS, ##P < 0.01; significantly different from OVA, *P < 0.05, **P < 0.01.